This article explores the effectiveness of modern inhalation therapy in the treatment of Chronic Obstructive Pulmonary Disease (COPD). COPD is a progressive respiratory condition that significantly impairs airflow and breathing quality. In recent years, inhalation therapy has become a cornerstone of COPD management due to its ability to deliver medication directly to the lungs, ensuring rapid relief and minimal systemic side effects. The article highlights various types of inhalers, their mechanisms of action, and recent advancements in inhalation technology. Clinical studies and patient outcomes are discussed to assess the efficacy and advantages of this therapeutic approach. The findings support that modern inhalation therapy plays a crucial role in improving patients' quality of life and slowing disease progression.

Chronic Obstructive Pulmonary Disease, COPD, Inhalation therapy, Bronchodilators, Pulmonary function, Respiratory treatment, Inhalers, Lung disease management, Modern medicine, Airflow obstruction.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management, and Prevention of COPD, 2024 Report.

Barnes, P. J. (2020). Inhaled corticosteroids in COPD: A critical review of benefits and risks. Chest, 157(3), 612–620.

Celli, B. R., & Wedzicha, J. A. (2019). Update on clinical aspects of chronic obstructive pulmonary disease. New England Journal of Medicine, 381(13), 1257–1266.

Vogelmeier, C. F., et al. (2017). Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. American Journal of Respiratory and Critical Care Medicine, 195(5), 557–582.

Lavorini, F., et al. (2019). Inhaler technique and patient adherence to inhaled medications. Respiratory Medicine, 156, 1–9.

Miravitlles, M., et al. (2020). Management of COPD in the era of precision medicine. European Respiratory Review, 29(155), 190113.

Mahler, D. A. (2021). The importance of symptoms in the management of chronic obstructive pulmonary disease. Medical Clinics, 105(5), 787–802.

Vestbo, J., et al. (2018). Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax, 73(10), 891–895.

Bafadhel, M., et al. (2018). Precision medicine in patients with COPD: Where are we and where do we need to go? European Respiratory Journal, 52(4), 1800614.

Han, M. K., et al. (2021). Chronic obstructive pulmonary disease phenotypes: The future of COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease, 18(1), 1–10.

Lipson, D. A., et al. (2018). Once-daily single-inhaler triple versus dual therapy in patients with COPD. New England Journal of Medicine, 378(18), 1671–1680.

Singh, D., et al. (2019). Inhaled therapies for chronic obstructive pulmonary disease: A review of current and emerging options. Clinical Therapeutics, 41(5), 776–792.

Ferguson, G. T., et al. (2020). Patient-centered care in COPD: Management strategies and implementation. International Journal of Chronic Obstructive Pulmonary Disease, 15, 2477–2491.

Usmani, O. S., et al. (2021). The role of inhaler devices in the treatment of airways disease. Respiratory Medicine, 184, 106457.